iTeos Therapeutics, Inc. (ITOS)

NASDAQ: ITOS · IEX Real-Time Price · USD

15.73

-0.57 (-3.50%)

At close: Jul 19, 2024, 4:00 PM

16.16

+0.43 (2.73%)

Pre-market: Jul 22, 2024, 7:56 AM EDT

iTeos Therapeutics Employees

iTeos Therapeutics had 157 employees as of December 31, 2023. The number of employees increased by 32 or 25.60% compared to the previous year.

Employees

157

Change (1Y)

32

Growth (1Y)

25.60%

Revenue / Employee

n/a

Profits / Employee

-$861,834

Market Cap

568.21M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	157	32	25.60%
Dec 31, 2022	125	31	32.98%
Dec 31, 2021	94	32	51.61%
Dec 31, 2020	62	19	44.19%
Dec 31, 2019	43	-	-

Related Stocks

Company Name	Employees
Castle Biosciences	610
Quanterix	441
National Research	435
Pharming Group	382
Verve Therapeutics	255
Alector	244
Mind Medicine (MindMed)	57
GH Research	49

Employee Rankings

ITOS News

14 days ago - iTeos Announces First Patient Dosed in GALAXIES Lung-301 Phase 3 Study, Earning $35 Million in Milestones from GSK - GlobeNewsWire
5 weeks ago - iTeos and GSK Initiate GALAXIES Lung-301 Phase 3 Study, Assessing Belrestotug and Dostarlimab in Previously Untreated, Unresectable Locally Advanced / Metastatic PD-L1 Selected Non-Small Cell Lung Cancer - GlobeNewsWire
2 months ago - iTeos Therapeutics to raise $120 million via registered direct offering - Invezz
2 months ago - iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
2 months ago - iTeos Therapeutics Announces $120 Million Registered Direct Offering - GlobeNewsWire
3 months ago - iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024 - GlobeNewsWire
4 months ago - iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors - GlobeNewsWire
4 months ago - iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates - GlobeNewsWire